Gabapentin
From Anvita Health Wiki
Contents |
More Specific Terms
Introduction
- Tradename: Neurontin.
Indications
- partial seizures
- panic disorder
- anxiety disorder
- attention deficit disorder
- neuropathic pain syndrome
- post herpetic neuralgia ( FDA approved) [7]
- diabetic neuropathy [7]
- fibromyalgia [11]
- off-label use, effectiveness questionable [12]; number needed to treat = number needed to harm = 8
- alcohol & benzodiazepine withdrawal
- low back pain
- migraine headache [5], prophylaxis [7]
- behavioral & psychological symptoms of dementia [6]
- hot flashes [7]
Contraindications
- NOT useful for bipolar disorder, restless legs syndrome, muscle cramps, hiccups [7]
- NOT useful for bipolar disorder, restless legs syndrome, muscle cramps, hiccups [7]
Dosage
- start 300 mg PO QHS
- increase over a few days to 300-600 mg PO TID
- max 3.6 g/day
- therapeutic doses > 900 mg/day
- Pediatrics: Start 15 mg/kg/day, max 45 mg/kg/day.
- Tabs: 100, 300, 400 mg. Dose adjustment in renal failure:
* creatinine clearance dose * > 60 mL/min 400 mg TID * 30-60 mL/min 300 mg BID * 15-30 mL/min 300 mg QD * < 15 mL/min 300 mg QOD
- 200-300 mg following each 4 hours of hemodialysis
Pharmacokinetics
- oral bioavailability is about 60%
- largely NOT bound to plasma proteins
- excreted unchanged in the urine
- elimination 1/2life is 5-7 hours
- elimination via kidney
- 1/2life = 5-7 hours
- protein binding = 0 %
- elimination by hemodialysis = +
Adverse-effects
- neurologic (common > 10%)
- systemic (less common 1-10%)
- pruritis, dyspepsia, dryness of throat/mouth, constipation, back pain, peripheral edema, myalgia, impotence, leukopenia, weight gain*, rhinitis, pharyngitis, cough, vasodilation
- 25 cases of suicide reported in patients on neurontin; no proof of link to neurontin [8]
- no evidence of cognitive impairment [10]
- * common in elderly [10]
Drug-interactions
- antacids decrease bioavailability of gabapentin
Mechanism-of-action
- structurally related to GABA, but does not interact with GABA receptors
- binds to alpha-2 delta subunit of voltage-gated Ca+2 channel
- membrane stabilizer
- may affect hypothalamic thermoregulatory centers
More General Terms
Additional Terms
Internet Database
PubChem: 3446
References
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 702
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- Kaiser Permanente Northern California Regional Drug Formulary, 1998
- Prescriber's Letter 8(6):34 2001
- Miller L, Annals of Pharmacotherapy 35:427, 2001 (case report & literature review)
- Prescriber's Letter 10(8):48 2003
- Prescriber's Letter 11(10): 2004 Neurontin Use and the Risk of Suicide Detail-Document#: [1] (subscription needed) [2]
- Journal Watch 25(9):74, 2005 Salinsky MC, Storzbach D, Spencer DC, Oken BS, Landry T, Dodrill CB. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology. 2005 Mar 8;64(5):792-8. PMID: [3]
- Journal Watch 25(15):118-19, 2005 Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, Spitz M, Frederick T, Towne A, Carter GS, Marks W, Felicetta J, Tomyanovich ML; VA Cooperative Study 428 Group. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. 2005 Jun 14;64(11):1868-73. PMID: [4]
- Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE Jr, Welge JA, Bishop F, Stanford KE, Hess EV, Hudson JI. Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007 Mar 28;56(4):1336-1344 [Epub ahead of print] PMID: [5]
- Prescriber's Letter 17(5): 2010 Off-label Uses of Gabapentin: More Scrutiny Detail-Document#: [6] (subscription needed) [7]
- Prescriber's Letter 18(11): 2011 Gralise (Extended-Release Gabapentin) Detail-Document#: [8] (subscription needed) [9]
